Immunology

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 309 Experts worldwide ranked by ideXlab platform

Mariana Castells - One of the best experts on this subject based on the ideXlab platform.

David M Lang - One of the best experts on this subject based on the ideXlab platform.

  • contact dermatitis a practice parameter update 2015
    The Journal of Allergy and Clinical Immunology: In Practice, 2015
    Co-Authors: Luz Fonacier, David M Lang, Richard A Nicklas, Joann Blessingmoore, David I Bernstein, David A Khan, John Oppenheimer, Karin A Pacheco, Linn D Holness, Jay M Portnoy
    Abstract:

    This parameter was developed by the Joint Task Force on Practice Parameters, which represents the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma & Immunology. The AAAAI and the ACAAI have jointly accepted responsibility for establishing "Contact Dermatitis: A Practice Parameter-Update 2015." This is a complete and comprehensive document at the current time. The medical environment is changing and not all recommendations will be appropriate or applicable to all patients. Because this document incorporated the efforts of many participants, no single individual, including members serving on the Joint Task Force, are authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information or interpretation of this practice parameter by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by the pharmaceutical industry in drug development or promotion. Previously published practice parameters of the Joint Task Force on Practice Parameters for Allergy & Immunology are available at http://www.JCAAI.org or http://www.allergyparameters.org.

  • international consensus on hereditary and acquired angioedema
    Annals of Allergy Asthma & Immunology, 2012
    Co-Authors: David M Lang, Werner Aberer, Jonathan A Bernstein, Hiok Hee Chng, A S Grumach, Michihiro Hide, Marcus Maurer, Richard W Weber, Bruce L Zuraw
    Abstract:

    *Allergy/Immunology, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio yDepartment of Dermatology, Medical University of Graz, Graz, Austria zDepartment of Internal Medicine, Division of Immunology/Allergy, University of Cincinnati, Cincinnati, Ohio xDepartment of Rheumatology, Allergy, and Immunology Tan Tock Seng Hospital, Singapore jj Faculty of Medicine ABC, Sao Paulo, Brazil {Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan Department of Dermatology and Allergy, Allergie-Centrum-Charite, Charite e Universitatsmedizin Berlin, Germany **Department of Medicine, Division of Allergy/Immunology, National Jewish Health, Denver, Colorado yyDepartment of Medicine, Division of Rheumatology, Allergy, and Immunology, University of San Diego, San Diego, California

  • the diagnosis and management of rhinitis an updated practice parameter
    The Journal of Allergy and Clinical Immunology, 2008
    Co-Authors: Dana Wallace, David M Lang, Richard A Nicklas, Joann Blessingmoore, Mark S Dykewicz, David I Bernstein, David A Khan, John Oppenheimer, Jay M Portnoy, Christopher Randolph
    Abstract:

    These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma and Immunology; and the Joint Council of Allergy, Asthma and Immunology. The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI) have jointly accepted responsibility for establishing "The diagnosis and Management of Rhinitis: An Updated Practice Parameter." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma and Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.

  • the diagnosis and management of sinusitis a practice parameter update
    The Journal of Allergy and Clinical Immunology, 2005
    Co-Authors: Raymond G Slavin, Michael A Kaliner, Leonard I Bernstein, Joann Blessingmoore, David A Khan, Sheldon L Spector, David W Kennedy, Frank S Virant, Ellen R Wald, David M Lang
    Abstract:

    These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology; the American College of Allergy, Asthma and Immunology; and the Joint Council of Allergy, Asthma and Immunology. The American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI) have jointly accepted responsibility for establishing "The diagnosis and management of sinusitis: a practice parameter update." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or the ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma and Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.

Pascal Demoly - One of the best experts on this subject based on the ideXlab platform.

  • Important questions in drug allergy and hypersensitivity: consensus papers from the 2018 AAAAI/WAO international drug allergy symposium
    World Allergy Organization Journal, 2018
    Co-Authors: Pascal Demoly, Mariana Castells
    Abstract:

    This article is one of a series of international consensus documents developed from the International Drug Allergy Symposium held at the Joint Congress of the American Academy of Allergy, Asthma & Immunology/World Allergy Organization on March 1, 2018, in Orlando, Florida, USA. The symposium was sponsored by The Journal of Allergy and Clinical Immunology, The Journal of Allergy and Clinical Immunology: In Practice, and The World Allergy Organization Journal and chaired by Mariana Castells, MD, PhD, and Pascal Demoly, MD, PhD.

  • important questions in drug allergy and hypersensitivity consensus papers from the 2018 aaaai wao international drug allergy symposium
    World Allergy Organization Journal, 2018
    Co-Authors: Pascal Demoly, Mariana Castells
    Abstract:

    This article is one of a series of international consensus documents developed from the International Drug Allergy Symposium held at the Joint Congress of the American Academy of Allergy, Asthma & Immunology/World Allergy Organization on March 1, 2018, in Orlando, Florida, USA. The symposium was sponsored by The Journal of Allergy and Clinical Immunology, The Journal of Allergy and Clinical Immunology: In Practice, and The World Allergy Organization Journal and chaired by Mariana Castells, MD, PhD, and Pascal Demoly, MD, PhD.

  • Allergen immunotherapy: therapeutic vaccines for allergic diseases
    Annals of allergy asthma & immunology : official publication of the American College of Allergy Asthma & Immunology, 1998
    Co-Authors: Jean Bousquet, Richard F. Lockey, H.-j. Malling, E. Alvarez-cuesta, Giorgio Walter Canonica, Martin D. Chapman, P. J. Creticos, J. M. Dayer, Stephen R. Durham, Pascal Demoly
    Abstract:

    ABBREVIATIONS AAAAI: American Academy of Allergy, Asthma and Immunology AU: Allergy Unit BAU: Bioequivalent Allergy Unit BU: Biologic Unit CBER: Center for Biologic Evaluation and Research EAACI: European Academy of Allergy and Clinical Immunology EU: European Union IAACI: International Association of Allergy and Clinical Immunology IU: International Unit IUIS: International Union of Immunological Societies PNU: protein nitrogen unit

Joann Blessingmoore - One of the best experts on this subject based on the ideXlab platform.

  • contact dermatitis a practice parameter update 2015
    The Journal of Allergy and Clinical Immunology: In Practice, 2015
    Co-Authors: Luz Fonacier, David M Lang, Richard A Nicklas, Joann Blessingmoore, David I Bernstein, David A Khan, John Oppenheimer, Karin A Pacheco, Linn D Holness, Jay M Portnoy
    Abstract:

    This parameter was developed by the Joint Task Force on Practice Parameters, which represents the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma & Immunology. The AAAAI and the ACAAI have jointly accepted responsibility for establishing "Contact Dermatitis: A Practice Parameter-Update 2015." This is a complete and comprehensive document at the current time. The medical environment is changing and not all recommendations will be appropriate or applicable to all patients. Because this document incorporated the efforts of many participants, no single individual, including members serving on the Joint Task Force, are authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information or interpretation of this practice parameter by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by the pharmaceutical industry in drug development or promotion. Previously published practice parameters of the Joint Task Force on Practice Parameters for Allergy & Immunology are available at http://www.JCAAI.org or http://www.allergyparameters.org.

  • the diagnosis and management of rhinitis an updated practice parameter
    The Journal of Allergy and Clinical Immunology, 2008
    Co-Authors: Dana Wallace, David M Lang, Richard A Nicklas, Joann Blessingmoore, Mark S Dykewicz, David I Bernstein, David A Khan, John Oppenheimer, Jay M Portnoy, Christopher Randolph
    Abstract:

    These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma and Immunology; and the Joint Council of Allergy, Asthma and Immunology. The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI) have jointly accepted responsibility for establishing "The diagnosis and Management of Rhinitis: An Updated Practice Parameter." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma and Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.

  • the diagnosis and management of sinusitis a practice parameter update
    The Journal of Allergy and Clinical Immunology, 2005
    Co-Authors: Raymond G Slavin, Michael A Kaliner, Leonard I Bernstein, Joann Blessingmoore, David A Khan, Sheldon L Spector, David W Kennedy, Frank S Virant, Ellen R Wald, David M Lang
    Abstract:

    These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology; the American College of Allergy, Asthma and Immunology; and the Joint Council of Allergy, Asthma and Immunology. The American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI) have jointly accepted responsibility for establishing "The diagnosis and management of sinusitis: a practice parameter update." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or the ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma and Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.

  • stinging insect hypersensitivity a practice parameter update
    The Journal of Allergy and Clinical Immunology, 2004
    Co-Authors: John E Moffitt, David B K Golden, Robert E Reisman, Rufus E Lee, Richard A Nicklas, Theodore M Freeman, Richard D Deshazo, James M Tracy, Leonard I Bernstein, Joann Blessingmoore
    Abstract:

    These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology; the American College of Allergy, Asthma and Immunology; and the Joint Council of Allergy, Asthma and Immunology. The American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI) have jointly accepted responsibility for establishing the "Stinging insect hypersensitivity: A Practice Parameter Update." Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or the ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma and Immunology. This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients.

Göran Berg - One of the best experts on this subject based on the ideXlab platform.

Related terms

Immunology - 15 days free trial to Access Experts & Abstracts